Hygieia Group Limited (1650) AI Stock Analysis

• Market Cap: HK$180.00M
• Dividend Yield: 12.75%
• Average Volume (3M): 484.80K
• Price to Earnings (P/E): 17.6
• Beta (1Y): 0.11
• Revenue Growth: 7.94%
• EPS Growth: 18.60%
• Country: HK
• Employees: 2,690
• Sector: Industrials
• Sector Strength: 72
• Industry: Consulting Services
• EPS (TTM): <0.01
• Shares Outstanding: 2,000,000,000
• 10 Day Avg. Volume: 704,800
• 30 Day Avg. Volume: 484,800
• PEG Ratio: 0.34
• Price to Book (P/B): 0.92
• Price to Sales (P/S): 0.34
• P/FCF Ratio: 17.10
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 62 Neutral
• Price Target: HK$0.09 ▼(-7.00% Downside)

Hygieia Group Limited's overall stock score reflects a stable financial foundation with strong equity and low leverage. However, profitability margins are under pressure, and technical indicators suggest weak momentum. The high dividend yield is a positive aspect but may also indicate underlying risks.

Positive Factors

Revenue Growth

Consistent revenue growth indicates a strong demand for Hygieia's healthcare solutions, reflecting successful market penetration and product adoption.

Financial Stability

A strong equity position and low leverage provide Hygieia with financial stability, enabling it to withstand economic fluctuations and invest in growth opportunities.

Cash Generation

Improved cash flow generation enhances Hygieia's ability to fund operations and strategic initiatives, supporting long-term growth and financial health.

Negative Factors

Profitability Margins

Low profitability margins suggest challenges in cost management and efficiency, which could hinder long-term profitability unless addressed.

Net Profit Margin

A low net profit margin indicates difficulty in translating revenue growth into bottom-line profits, which may impact long-term shareholder value.

Free Cash Flow

Limited free cash flow relative to net income may restrict Hygieia's ability to reinvest in growth initiatives and manage financial obligations effectively.

Hygieia Group Limited Business Overview & Revenue Model

Company Description

Hygieia Group Limited, an investment holding company, provides general cleaning services in Singapore and Thailand. The company offers general cleaning works for various public and private venues, including medical centres, shopping malls, commercial and industrial buildings, schools, hotels, and private condominiums, as well as public access areas in town councils. It also provides general cleaning works for private customers at private residences, an office, and industrial buildings. The company was founded in 1991 and is headquartered in Singapore. Hygieia Group Limited is a subsidiary of TEK Assets Management Limited.

How the Company Makes Money

Hygieia Group Limited generates revenue through multiple streams, primarily by selling its proprietary medical devices and diagnostic tools to healthcare providers, hospitals, and clinics. The company also offers subscription-based telehealth services, which provide ongoing revenue through monthly fees for access to its digital health platforms. Additionally, Hygieia Group Limited has entered into strategic partnerships with pharmaceutical companies and research institutions, allowing for collaborative development projects that can lead to licensing agreements and shared revenue models. These partnerships enhance the company’s research capabilities and expand its market reach, thereby contributing significantly to its earnings.

Hygieia Group Limited Financial Statement Overview

Summary

Hygieia Group Limited demonstrates a solid financial foundation with strong equity and low leverage, providing stability. However, profitability margins are under pressure, indicating a need for operational improvements. Cash flow generation is healthy, though there is potential to enhance free cash flow.

Income Statement

The company has shown a consistent increase in revenue over the past years, with a notable revenue growth rate of 12.27% from 2023 to 2024. Gross profit margin improved slightly to 12.91% in 2024, indicating better cost management. However, the net profit margin remains low at 1.01%, suggesting challenges in converting revenue into profit. The EBIT and EBITDA margins are also relatively low, reflecting potential inefficiencies in operations.

Balance Sheet

The balance sheet reflects a strong equity position with an equity ratio of 67.87% in 2024, indicating financial stability. The debt-to-equity ratio is low at 0.14, suggesting conservative leverage. Return on equity improved to 2.72%, but remains modest, highlighting room for enhancing shareholder returns.

Cash Flow

Operating cash flow has improved, with a positive free cash flow growth rate of 2.74% from 2023 to 2024. The operating cash flow to net income ratio is 2.87, indicating strong cash generation relative to net income. However, the free cash flow to net income ratio is 1.98, suggesting that while cash flow is positive, there is limited free cash flow relative to net income.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	77.07M	74.70M	66.54M	63.42M	71.61M	72.61M
Gross Profit	11.80M	9.65M	8.99M	8.60M	14.45M	22.16M
EBITDA	2.37M	516.00K	3.24M	1.48M	9.02M	12.38M
Net Income	1.75M	756.00K	454.00K	-1.60M	5.14M	8.80M
Balance Sheet
Total Assets	37.74M	40.99M	44.48M	46.87M	56.53M	50.16M
Cash, Cash Equivalents and Short-Term Investments	15.13M	18.43M	22.58M	27.52M	31.02M	22.63M
Total Debt	2.85M	3.90M	6.04M	7.52M	9.47M	7.45M
Total Liabilities	11.69M	13.06M	14.38M	15.27M	18.84M	17.57M
Stockholders Equity	25.90M	27.82M	30.05M	31.60M	37.70M	32.55M
Cash Flow
Free Cash Flow	7.26M	1.50M	146.00K	4.14M	8.79M	6.58M
Operating Cash Flow	7.68M	2.17M	1.04M	5.08M	9.87M	7.22M
Investing Cash Flow	2.82M	2.60M	-815.00K	-10.41M	1.72M	-3.11M
Financing Cash Flow	-8.10M	-6.64M	-5.52M	-8.19M	-675.00K	3.43M

Hygieia Group Limited Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.10
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Negative
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1650, the sentiment is Positive. The current price of 0.1 is above the 20-day moving average (MA) of 0.09, above the 50-day MA of 0.09, and above the 200-day MA of 0.08, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 95.88 is Negative, neither overbought nor oversold. The STOCH value of 115.19 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1650.

Hygieia Group Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	63 Neutral	$10.79B	15.43	7.44%	2.01%	2.89%	-14.66%
1650	62 Neutral	HK$180.00M	17.65	6.39%	12.75%	7.94%	18.60%
3893	46 Neutral	HK$197.82M	―	―	―	-24.93%	-72.69%
8501	46 Neutral	HK$97.98M	-24.87	-5.93%	―	50.50%	27.48%
8455	45 Neutral	HK$48.00M	-3.09	-601.82%	―	4.00%	13.57%
1376	43 Neutral	HK$127.00M	-20.48	29.87%	―	1.93%	-158.33%
1867	42 Neutral	HK$418.32M	-8.36	-51.34%	―	-30.47%	-57.80%

Hygieia Group Limited Corporate Events

Hygieia Group Limited Announces Changes to Nomination Committee

Hygieia Group Limited has announced a change in the composition of its Nomination Committee. Ms. Toh Lek Siew has been appointed as a member, effective August 28, 2025. This change is expected to enhance the effectiveness and diversity of the Board, thereby improving the company’s corporate governance practices.

Hygieia Group Limited Announces Board Composition and Committee Roles

Hygieia Group Limited has announced the composition of its board of directors, which includes both executive and independent non-executive directors. The board is chaired by Mr. Toh Eng Kui, with Mr. Peh Poon Chew and Ms. Toh Lek Siew also serving as executive directors. Independent non-executive directors include Mr. Leung Chi Hang Benson, Mr. Lew Chern Yong, and Mr. Wong Yuk. The announcement also details the membership of the company’s three board committees: Audit, Nomination, and Remuneration. This update provides stakeholders with clarity on the governance structure of the company, which is crucial for maintaining transparency and accountability in its operations.

Hygieia Group Limited Announces Upcoming Board Meeting for Interim Results

Hygieia Group Limited has announced a board meeting scheduled for 28 August 2025 to discuss and approve the unaudited interim results for the first half of 2025 and consider the payment of an interim dividend. This meeting could have implications for the company’s financial strategy and shareholder returns, potentially affecting its market position and investor relations.